Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS)

Velidi H. Rao, George E. Lees, Clifford E. Kashtan, Ryochi Nemori, Rakesh K Singh, Daniel T. Meehan, Kathyrn Rodgers, Brian R. Berridge, Gautam Bhattacharya, Dominic E Cosgrove

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Alport syndrome is a group of genetic disorders resulting from mutations in either the α3(IV), α4(IV) or α5(IV) collagen chains. The disease is characterized by a progressive glomerulonephritis, usually associated with a high-frequency specific sensorineural hearing loss, dot and fleck retinopathy, and lens abnormalities. Dogs with naturally occurring genetic disorders of basement membrane collagen (type IV) may serve as animal models of Alport syndrome. In this study, a well-characterized naturally occurring canine model was employed to demonstrate a potential role for matrix metalloproteinases (MMPs) in Alport renal disease pathogenesis. Methods: Adolescent male dogs that developed renal failure were euthanized and necropsied. Clinicopathologic features of the disease were characterized, and kidneys from normal and Alport dogs were analyzed by gelatin zymography, Western blotting, in situ zymography, immunohistology, and by reverse transcription polymerase chain reaction (RT-PCR) for expression of MMP-2, MMP-9, and membrane type 1-MMP (MT1-MMP). Results: Affected dogs developed proteinuria and rapidly progressive juvenile-onset chronic renal failure. The activities of MMP-2 and MMP-9 were significantly induced in Alport kidney. In situ zymography confirmed elevated active metalloproteinases in kidney cryosections of affected dogs. The mRNAs encoding MMP-2, MMP-9 and MT1-MMP were also increased in Alport dogs suggesting that elevated expression of MMPs reflects events in the progression of Alport syndrome in dogs. Conclusion: Elevated expression of MMP-2, MMP-9, and MT1-MMP is observed in fibrotic renal cortex from X-linked Alport syndrome dogs. These findings suggest that MMPs may play an important role in matrix accumulation associated with progressive renal scarring in this model.

Original languageEnglish (US)
Pages (from-to)1736-1748
Number of pages13
JournalKidney International
Volume63
Issue number5
DOIs
StatePublished - May 1 2003

Fingerprint

Hereditary Nephritis
Gelatinases
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Collagenases
Matrix Metalloproteinases
Canidae
Dogs
Membranes
Kidney
Inborn Genetic Diseases
Matrix Metalloproteinase 14
Collagen Type IV
Sensorineural Hearing Loss
Metalloproteases
Gelatin
Glomerulonephritis
Proteinuria
Lenses
Reverse Transcription

Keywords

  • Alport syndrome
  • Fibrosis
  • Matrix metalloproteinase

ASJC Scopus subject areas

  • Nephrology

Cite this

Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). / Rao, Velidi H.; Lees, George E.; Kashtan, Clifford E.; Nemori, Ryochi; Singh, Rakesh K; Meehan, Daniel T.; Rodgers, Kathyrn; Berridge, Brian R.; Bhattacharya, Gautam; Cosgrove, Dominic E.

In: Kidney International, Vol. 63, No. 5, 01.05.2003, p. 1736-1748.

Research output: Contribution to journalArticle

Rao, Velidi H. ; Lees, George E. ; Kashtan, Clifford E. ; Nemori, Ryochi ; Singh, Rakesh K ; Meehan, Daniel T. ; Rodgers, Kathyrn ; Berridge, Brian R. ; Bhattacharya, Gautam ; Cosgrove, Dominic E. / Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). In: Kidney International. 2003 ; Vol. 63, No. 5. pp. 1736-1748.
@article{285b8932ecd04dbfa5ec775582d0c649,
title = "Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS)",
abstract = "Background: Alport syndrome is a group of genetic disorders resulting from mutations in either the α3(IV), α4(IV) or α5(IV) collagen chains. The disease is characterized by a progressive glomerulonephritis, usually associated with a high-frequency specific sensorineural hearing loss, dot and fleck retinopathy, and lens abnormalities. Dogs with naturally occurring genetic disorders of basement membrane collagen (type IV) may serve as animal models of Alport syndrome. In this study, a well-characterized naturally occurring canine model was employed to demonstrate a potential role for matrix metalloproteinases (MMPs) in Alport renal disease pathogenesis. Methods: Adolescent male dogs that developed renal failure were euthanized and necropsied. Clinicopathologic features of the disease were characterized, and kidneys from normal and Alport dogs were analyzed by gelatin zymography, Western blotting, in situ zymography, immunohistology, and by reverse transcription polymerase chain reaction (RT-PCR) for expression of MMP-2, MMP-9, and membrane type 1-MMP (MT1-MMP). Results: Affected dogs developed proteinuria and rapidly progressive juvenile-onset chronic renal failure. The activities of MMP-2 and MMP-9 were significantly induced in Alport kidney. In situ zymography confirmed elevated active metalloproteinases in kidney cryosections of affected dogs. The mRNAs encoding MMP-2, MMP-9 and MT1-MMP were also increased in Alport dogs suggesting that elevated expression of MMPs reflects events in the progression of Alport syndrome in dogs. Conclusion: Elevated expression of MMP-2, MMP-9, and MT1-MMP is observed in fibrotic renal cortex from X-linked Alport syndrome dogs. These findings suggest that MMPs may play an important role in matrix accumulation associated with progressive renal scarring in this model.",
keywords = "Alport syndrome, Fibrosis, Matrix metalloproteinase",
author = "Rao, {Velidi H.} and Lees, {George E.} and Kashtan, {Clifford E.} and Ryochi Nemori and Singh, {Rakesh K} and Meehan, {Daniel T.} and Kathyrn Rodgers and Berridge, {Brian R.} and Gautam Bhattacharya and Cosgrove, {Dominic E}",
year = "2003",
month = "5",
day = "1",
doi = "10.1046/j.1523-1755.2003.00939.x",
language = "English (US)",
volume = "63",
pages = "1736--1748",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS)

AU - Rao, Velidi H.

AU - Lees, George E.

AU - Kashtan, Clifford E.

AU - Nemori, Ryochi

AU - Singh, Rakesh K

AU - Meehan, Daniel T.

AU - Rodgers, Kathyrn

AU - Berridge, Brian R.

AU - Bhattacharya, Gautam

AU - Cosgrove, Dominic E

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Background: Alport syndrome is a group of genetic disorders resulting from mutations in either the α3(IV), α4(IV) or α5(IV) collagen chains. The disease is characterized by a progressive glomerulonephritis, usually associated with a high-frequency specific sensorineural hearing loss, dot and fleck retinopathy, and lens abnormalities. Dogs with naturally occurring genetic disorders of basement membrane collagen (type IV) may serve as animal models of Alport syndrome. In this study, a well-characterized naturally occurring canine model was employed to demonstrate a potential role for matrix metalloproteinases (MMPs) in Alport renal disease pathogenesis. Methods: Adolescent male dogs that developed renal failure were euthanized and necropsied. Clinicopathologic features of the disease were characterized, and kidneys from normal and Alport dogs were analyzed by gelatin zymography, Western blotting, in situ zymography, immunohistology, and by reverse transcription polymerase chain reaction (RT-PCR) for expression of MMP-2, MMP-9, and membrane type 1-MMP (MT1-MMP). Results: Affected dogs developed proteinuria and rapidly progressive juvenile-onset chronic renal failure. The activities of MMP-2 and MMP-9 were significantly induced in Alport kidney. In situ zymography confirmed elevated active metalloproteinases in kidney cryosections of affected dogs. The mRNAs encoding MMP-2, MMP-9 and MT1-MMP were also increased in Alport dogs suggesting that elevated expression of MMPs reflects events in the progression of Alport syndrome in dogs. Conclusion: Elevated expression of MMP-2, MMP-9, and MT1-MMP is observed in fibrotic renal cortex from X-linked Alport syndrome dogs. These findings suggest that MMPs may play an important role in matrix accumulation associated with progressive renal scarring in this model.

AB - Background: Alport syndrome is a group of genetic disorders resulting from mutations in either the α3(IV), α4(IV) or α5(IV) collagen chains. The disease is characterized by a progressive glomerulonephritis, usually associated with a high-frequency specific sensorineural hearing loss, dot and fleck retinopathy, and lens abnormalities. Dogs with naturally occurring genetic disorders of basement membrane collagen (type IV) may serve as animal models of Alport syndrome. In this study, a well-characterized naturally occurring canine model was employed to demonstrate a potential role for matrix metalloproteinases (MMPs) in Alport renal disease pathogenesis. Methods: Adolescent male dogs that developed renal failure were euthanized and necropsied. Clinicopathologic features of the disease were characterized, and kidneys from normal and Alport dogs were analyzed by gelatin zymography, Western blotting, in situ zymography, immunohistology, and by reverse transcription polymerase chain reaction (RT-PCR) for expression of MMP-2, MMP-9, and membrane type 1-MMP (MT1-MMP). Results: Affected dogs developed proteinuria and rapidly progressive juvenile-onset chronic renal failure. The activities of MMP-2 and MMP-9 were significantly induced in Alport kidney. In situ zymography confirmed elevated active metalloproteinases in kidney cryosections of affected dogs. The mRNAs encoding MMP-2, MMP-9 and MT1-MMP were also increased in Alport dogs suggesting that elevated expression of MMPs reflects events in the progression of Alport syndrome in dogs. Conclusion: Elevated expression of MMP-2, MMP-9, and MT1-MMP is observed in fibrotic renal cortex from X-linked Alport syndrome dogs. These findings suggest that MMPs may play an important role in matrix accumulation associated with progressive renal scarring in this model.

KW - Alport syndrome

KW - Fibrosis

KW - Matrix metalloproteinase

UR - http://www.scopus.com/inward/record.url?scp=0242500841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242500841&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2003.00939.x

DO - 10.1046/j.1523-1755.2003.00939.x

M3 - Article

C2 - 12675849

AN - SCOPUS:0242500841

VL - 63

SP - 1736

EP - 1748

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -